Intratumoral CD103 + CD8 + T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma
Cancer Communications2023Vol. 43(10), pp. 1143–1163
Citations Over TimeTop 10% of 2023 papers
Siqi Ren, Tianjun Lan, Fan Wu, Suling Chen, Xue Jiang, Chuying Huo, Zitian Li, Shule Xie, Donghui Wu, Ruixin Wang, Yanyan Li, Lin Qiu, Guoxin Huang, Shurui Li, Xiaojuan Wang, Meifeng Cen, Tingting Cai, Zhaoyu Lin, Jinsong Li, Bowen Li
Abstract
Our study highlights the impact of intratumoral CD103+ CD8+ TILs density on NACI efficacy in different cancers, while the efforts to elevate its population warrant further clinical investigation.
Related Papers
- Regional chemoimmunotherapy for nonresectable metastatic liver disease of colorectal origin. A prospective randomized study.(2001)
- Chemoimmunotherapy with Krestin in acute leukemia.(1981)
- → Evolving Strategies in First-Line Chronic Lymphocytic Leukemia: Is There a Role for Chemoimmunotherapy?(2019)1 cited
- → Results of a Nonrandomized Trial in Malignant Melanoma Patients (Clark’s Stages III–V) Treated by Post-Surgical Chemoimmunotherapy(1979)8 cited
- → [Application of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC].(2023)1 cited